Paragangliomas Recruiting Phase 2 Trials for Dotatate (DB14554)

Back to Paragangliomas

Also known as: Paraganglioma / Paraganglion neoplasm / Paraganglion neoplasm NOS / Neoplasm of paraganglion (disorder) / [M]Paraganglioma NOS (morphologic abnormality) / Gangliocytic paraganglioma (disorder) / Gangliocytic paraganglioma (morphologic abnormality) / Paraganglioma (morphologic abnormality) / Paraganglioma (disorder)

Indication	Status	Phase
DBCOND0051744 (Paragangliomas)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03206060	Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma	Treatment	Amino acids (DB09393) Dotatate (DB14554) Lutetium Lu-177 (DB13982)
NCT04711135	Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs	Treatment	Dotatate (DB14554) Lutetium Lu 177 dotatate (DB13985)